The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data^.

Sarah C Rutherford, Eric N Stewart,Zhengming Chen,Amy Chadburn,Natasha E Wehrli,Koen van Besien,Peter Martin,Richard R Furman,John P Leonard,Leandro Cerchietti

LEUKEMIA & LYMPHOMA（2018）

引用 6|浏览27

暂无评分

摘要

Ribavirin, an antiviral drug used to treat infections including respiratory syncytial virus (RSV), interferes with the function of the eukaryotic translation initiation factor 4E (eIF4E) [1]. EIF4E...

查看译文

关键词

eif4e inhibitor ribavirin,potential antilymphoma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data.

The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data^.